NCT03809377View on ClinicalTrials.gov

Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2)

Active, not recruitingOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

May 9, 2019

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions
Cancer
Interventions
PROCEDURE

Blood donation during radiotherapy

Participants will be asked to donate a blood sample at 5 time points during and after radiotherapy

Trial Locations (1)

SM2 5PT

The Royal Marsden NHS Foundation Trust, Sutton

All Listed Sponsors
collaborator

Public Health England

OTHER_GOV

lead

Institute of Cancer Research, United Kingdom

OTHER